TransMedics Group, Inc.
TMDX
$68.94
$0.090.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.32M | 105.38M | 24.32M | 34.91M | 25.68M |
| Total Depreciation and Amortization | 11.16M | 6.97M | 6.05M | 6.73M | 6.14M |
| Total Amortization of Deferred Charges | 700.00K | 500.00K | 800.00K | -- | -- |
| Total Other Non-Cash Items | 16.71M | -73.00M | 10.47M | 9.79M | 9.73M |
| Change in Net Operating Assets | -11.35M | -5.34M | 27.93M | 40.19M | -44.40M |
| Cash from Operations | 24.53M | 34.51M | 69.57M | 91.61M | -2.86M |
| Capital Expenditure | -36.66M | -15.51M | -7.62M | -9.08M | -27.04M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -36.66M | -15.51M | -7.62M | -9.08M | -27.04M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.90M | 3.10M | 3.78M | 7.09M | 3.03M |
| Repurchase of Common Stock | -138.00K | 0.00 | -138.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.76M | 3.10M | 3.64M | 7.09M | 3.03M |
| Foreign Exchange rate Adjustments | -327.00K | 94.00K | 9.00K | 809.00K | 358.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.69M | 22.19M | 65.60M | 90.43M | -26.51M |